Ovrette | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Ovrette

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 30 USDMF, 12 CEP/COS, 3 JDMF, 8 EU WC, 22 NDC API, 18 Listed Suppliers

DEVELOPMENTS

66 Drugs in Development

66 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

528 FDF Dossiers, 137 FDA Orange Book, 289 Europe, 31 Canada, 16 Australia, 33 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A, SYSTEM;INTRAUTERINE - 52MG, TABLET;ORAL - 0.02MG;0.1MG, SYSTEM;INTRAUTERINE - 52MG, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR, TABLET;ORAL - 1.5MG

RELATED EXCIPIENT COMPANIES

5 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Cerata Pharmaceuticals LLP, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 17 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

53 Fillers, Diluents & Binders, 38 Coating Systems & Additives, 23 Granulation, 23 Direct Compression, 22 Controlled & Modified Release, 21 Disintegrants & Superdisintegrants, 17 Thickeners and Stabilizers, 14 Solubilizers, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Taste Masking, 9 Empty Capsules, 8 Topical, 7 Chewable & Orodispersible Aids, 7 Film Formers & Plasticizers, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Parenteral, 3 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Weekly News Recap #Phispers, 86 News #PharmaBuzz

GLOBAL SALES INFORMATION

45 US Medicaid Prescriptions, 15 Regulatory FDF Prices, 15 Annual Reports

MARKET PLACE

9 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

5 EDQM, 1 JP, 11 Others

Xls

Filters

Filters

FILTER :

filter Product Reset all filters

15 All

01 4Liletta

02 3Mirena Product Family

03 1Mirena product family

04 6Mirena/ Kyleena/ Jaydess

05 1MirenaTM product family

List of Suppliers

Product Main Page

01

Brand Name : Liletta

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Sexual Health

Currency : USD

2017 Revenue in Millions : 38

2016 Revenue in Millions : 23

Growth (%) : 63

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Liletta

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Sexual Health

Currency : USD

2018 Revenue in Millions : 51

2017 Revenue in Millions : 38

Growth (%) : 34%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Liletta

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Contraception

Currency : USD

2016 Revenue in Millions : 23

2015 Revenue in Millions : 15

Growth (%) : 53

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Liletta

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Urology

Currency : USD

2019 Revenue in Millions : 79

2018 Revenue in Millions : 51

Growth (%) : 55

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Mirena/ Kyleena/ Jaydess

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Urology

Currency : USD

2020 Revenue in Millions : 1,308

2019 Revenue in Millions : 1,479

Growth (%) : -12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Mirena/ Kyleena/ Jaydess

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Urology

Currency : USD

2021 Revenue in Millions : 1,288

2020 Revenue in Millions : 1,308

Growth (%) : 8

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Mirena/ Kyleena/ Jaydess

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Women's Health

Currency : USD

2022 Revenue in Millions : 1,341

2021 Revenue in Millions : 1,288

Growth (%) : 4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Mirena/ Kyleena/ Jaydess

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Women's Health

Currency : USD

2023 Revenue in Millions : 1,312

2022 Revenue in Millions : 1,341

Growth (%) : -5

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Mirena/ Kyleena/ Jaydess

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Women?s Health

Currency : USD

2024 Revenue in Millions : 1,334

2023 Revenue in Millions : 1,312

Growth (%) : 2

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Mirena Product Family

PEGS Boston Summit

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Levonorgestrel

Main Therapeutic Indication : Sexual Health

Currency : USD

2015 Revenue in Millions : 901

2014 Revenue in Millions : 1,065

Growth (%) : 18%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.